Toxicology and antitumor activity of tuftsin.
D000328:Adult; D000368:Aged; D000375:Aging; D000818:Animals; D002986:Clinical Trials as Topic; D003602:Cytotoxicity, Immunologic; D004285:Dogs; D005260:Female; D005354:Fibrosarcoma / Q000188:drug therapy; D006801:Humans; D007928:Lethal Dose 50; D007958:Leukocyte Count; D007964:Leukocytosis / Q000139:chemically induced; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D008875:Middle Aged; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000188:drug therapy*; D013154:Spleen / Q000166:cytology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014405:Tuftsin / Q000627:therapeutic use* / Q000633:toxicity
D014405:Tuftsin